Procoagulant protein levels are differentially increased during human endotoxemia

Journal of Thrombosis and Haemostasis

Volumn 1, Issue 5, 2003, Pages 1019-1023

  Reitsma, P H ^a   Branger, J ^a   Van Den Blink, B ^a   Weijer, S ^a   Van Der Poll, T ^a   Meijers, J C M ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Coagulation proteins; Inflammation; Risk factors; Venous thrombosis

Indexed keywords

EID: 12344287613     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1046/j.1538-7836.2003.00237.x     Document Type: Article

References (19)

1. Franco RF, Reitsma PH. Genetic risk factors of venous thrombosis. Hum Genet 2001; 109: 369-84.
2. Poort SR, Rosendaal FR, Reitsma PH, Bertina RM. A common genetic variation in the 3'-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 1996; 88: 3698-703.
3. Koster T, Blann AD, Briët E, Vandenbroucke JP, Rosendaal FR. Role of clotting factor VIII in effect of von Willebrand factor on occurrence of deep-vein thrombosis. Lancet 1995; 345: 152-5.
4. O'Donnell J, Tuddenham EG, Manning R, Kemball-Cook G, Johnson D, Laffan M. High prevalence of elevated factor VIII levels in patients referred for thrombophilia screening: role of increased synthesis and relationship to the acute phase reaction. Thromb Haemost 1997; 77: 825-8.
5. van Hylckama Vlieg A, van der Linden IK, Bertina RM, Rosendaal FR. High levels of factor IX increase the risk of venous thrombosis. Blood 2000; 95: 3678-82.
6. Meijers JC, Tekelenburg WL, Bouma BN, Bertina RM, Rosendaal FR. High levels of coagulation factor XI as a risk factor for venous thrombosis. N Engl J Med 2000; 342: 696-701.
7. Kamphuisen PW, Eikenboom JC, Rosendaal FR, Koster T, Blann AD, Vos HL, Bertina RM. High factor VIII antigen levels increase the risk of venous thrombosis but are not associated with polymorphisms in the von Willebrand factor and factor VIII gene. Br J Haematol 2001; 115: 156-8.
8. Mansvelt EP, Laffan M, McVey JH, Tuddenham EG. Analysis of the F8 gene in individuals with high plasma factor VIII. C levels and associated venous thrombosis. Thromb Haemost 1998; 80: 561-5.
9. van Aken BE, Reitsma PH, Rosendaal FR. Interleukin 8 and venous thrombosis: evidence for a role of inflammation in thrombosis. Br J Haematol 2002; 116: 173-7.
10. van Aken BE, den Heijer M, Bos GM, van Deventer SJ, Reitsma PH. Recurrent venous thrombosis and markers of inflammation. Thromb Haemost 2000; 83: 536-9.
11. Noe DA, Murphy PA, Bell WR, Siegel JN. Acute-phase behavior of factor VIII procoagulant and other acute-phase reactants in rabbits. Am J Physiol 1989; 257: R49-56.
12. Gabay C, Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 1999; 340: 448-54.
13. Korkmaz C, Ozdogan H, Kasapcopur O, Yazici H. Acute phase response in familial Mediterranean fever. Ann Rheum Dis 2002; 61: 79-81.
14. Van der Poll T, Van Deventer SJH. Endotoxemia in healthy subjects as a human model of inflammation. In: Cohen, J, Marshall, J, eds. The Immune Response in the Critically Ill. Heidelberg: Springer Verlag, 1999.
15. Pajkrt D, Van der Poll T, Levi M, Cutler DL, Affrime MB, Van den Ende A, Ten Cate JW, Van Deventer SJ. Interleukin-10 inhibits activation of coagulation and fibrinolysis during endotoxemia. Blood 1997; 89: 2701-5.
16. De Jonge E, Dekkers PE, Creasey AA, Hack CE, Paulson SK, Karim A, Kesecioglu A, Levi M, Van Deventer SJ, Van der Poll T. Tissue factor pathway inhibitor dose-dependently inhibits coagulation activation without influencing the fibrinolytic and cytokine response during human endotoxemia. Blood 2000; 95: 1124-9.
17. Verbon A, Dekkers PE, ten Hove T, Hack CE, Pribble JP, Turner T, Souza S, Axtelle T, Hoek FJ, Van Deventer SJ, Van der Poll T. IC14, an anti-CD 14 antibody, inhibits endotoxin-mediated symptoms and inflammatory responses in humans. J Immunol 2001; 166: 3599-605.
18. Gralnick HR, McKeown LP, Wilson OM, Williams SB, Elin RJ. von Willebrand factor release induced by endotoxin. J Lab Clin Med 1989; 113: 118-22.
19. Hollestelle MJ, Thinnes T, Crain K, Stiko A, Kruijt JK, Van Berkel TJ, Loskutoff DJ, Van Mourik JA. Tissue distribution of factor viii gene expression in vivo - a closer look. Thromb Haemost 2001; 86: 855-61.